Atcheson BA, Taylor PJ, Mudge DW, Johnson DW, Hawley CM, Campbell SB et al. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant. Br.J.Clin.Pharmacol. 2005;59(3):271-80.
Barten MJ, Shipkova M, Bartsch P, Dhein S, Streit F, Tarnok A et al. Mycophenolic Acid Interaction With Cyclosporine and Tacrolimus In Vitro and In Vivo: Evaluation of Additive Effects on Rat Blood Lymphocyte Function. Ther.Drug Monit. 2005;27(2):123-31.
Patel CG, Mendonza AE, Akhlaghi F, Majid O, Trull AK, Lee T et al. Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry. J Chromatogr.B Analyt.Technol.Biomed.Life Sci. 2004;813(1-2):287-94.
Premaud A, Rousseau A, Le Meur Y, Lachatre G, Marquet P. Comparison of Liquid Chromatography-Tandem Mass Spectrometry with a Commercial Enzyme-Multiplied Immunoassay for the Determination of Plasma MPA in Renal Transplant Recipients and Consequences for Therapeutic Drug Monitoring. Ther.Drug Monit. 2004;26(6):609-19.
Aresta A, Palmisano F, Zambonin CG, Schena P, Grandaliano G. Simultaneous determination of free mycophenolic acid and its glucuronide in serum of patients under mycophenolate mophetil therapy by ion-pair reversed-phase liquid chromatography with diode array UV detection. J Chromatogr.B Analyt.Technol.Biomed.Life Sci. 2004;810(2):197-202.
Shaw LM, Nawrocki A, Korecka M, Solari S, Kang J. Using established immunosuppressant therapy effectively: lessons from the measurement of mycophenolic Acid plasma concentrations. Ther.Drug Monit. 2004;26(4):347-51.
Mudge DW, Atcheson BA, Taylor PJ, Pillans PI, Johnson DW. Severe Toxicity Associated with a Markedly Elevated Mycophenolic Acid Free Fraction in a Renal Transplant Recipient. Ther.Drug Monit. 2004;26(4):453-5.
Atcheson BA, Taylor PJ, Kirkpatrick CM, Duffull SB, Mudge DW, Pillans PI et al. Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia. Ther.Drug Monit. 2004;26(3):284-6.
Streit F, Shipkova M, Armstrong VW, Oellerich M. Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic Acid. Clin Chem. 2004;50(1):152-9.
Atcheson B, Taylor PJ, Mudge DW, Johnson DW, Pillans PI, Tett SE. Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection. J Chromatogr.B Analyt.Technol.Biomed.Life Sci. 2004;799(1):157-63.
Khoschsorur G, Erwa W. Liquid chromatographic method for simultaneous determination of mycophenolic acid and its phenol- and acylglucuronide metabolites in plasma. J Chromatogr.B Analyt.Technol.Biomed.Life Sci. 2004;799(2):355-60.
Barten MJ, Shipkova M, Bartsch P, Dhein S, Streit F, Tarnok A et al. Mycophenolic Acid Interaction With Cyclosporine and Tacrolimus In Vitro and In Vivo: Evaluation of Additive Effects on Rat Blood Lymphocyte Function. Ther.Drug Monit. 2005;27(2):123-31.
Patel CG, Mendonza AE, Akhlaghi F, Majid O, Trull AK, Lee T et al. Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry. J Chromatogr.B Analyt.Technol.Biomed.Life Sci. 2004;813(1-2):287-94.
Premaud A, Rousseau A, Le Meur Y, Lachatre G, Marquet P. Comparison of Liquid Chromatography-Tandem Mass Spectrometry with a Commercial Enzyme-Multiplied Immunoassay for the Determination of Plasma MPA in Renal Transplant Recipients and Consequences for Therapeutic Drug Monitoring. Ther.Drug Monit. 2004;26(6):609-19.
Aresta A, Palmisano F, Zambonin CG, Schena P, Grandaliano G. Simultaneous determination of free mycophenolic acid and its glucuronide in serum of patients under mycophenolate mophetil therapy by ion-pair reversed-phase liquid chromatography with diode array UV detection. J Chromatogr.B Analyt.Technol.Biomed.Life Sci. 2004;810(2):197-202.
Shaw LM, Nawrocki A, Korecka M, Solari S, Kang J. Using established immunosuppressant therapy effectively: lessons from the measurement of mycophenolic Acid plasma concentrations. Ther.Drug Monit. 2004;26(4):347-51.
Mudge DW, Atcheson BA, Taylor PJ, Pillans PI, Johnson DW. Severe Toxicity Associated with a Markedly Elevated Mycophenolic Acid Free Fraction in a Renal Transplant Recipient. Ther.Drug Monit. 2004;26(4):453-5.
Atcheson BA, Taylor PJ, Kirkpatrick CM, Duffull SB, Mudge DW, Pillans PI et al. Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia. Ther.Drug Monit. 2004;26(3):284-6.
Streit F, Shipkova M, Armstrong VW, Oellerich M. Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic Acid. Clin Chem. 2004;50(1):152-9.
Atcheson B, Taylor PJ, Mudge DW, Johnson DW, Pillans PI, Tett SE. Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection. J Chromatogr.B Analyt.Technol.Biomed.Life Sci. 2004;799(1):157-63.
Khoschsorur G, Erwa W. Liquid chromatographic method for simultaneous determination of mycophenolic acid and its phenol- and acylglucuronide metabolites in plasma. J Chromatogr.B Analyt.Technol.Biomed.Life Sci. 2004;799(2):355-60.
Bioanalytics and Forensic Toxicology